In a recent study published in the Journal of Clinical Medicine, researchers investigated the B cell and humoral immune responses elicited against inactivated and recombinant severe acute respiratory ...
In a recent study published in Clinical Infectious Diseases, researchers longitudinally evaluated humoral immune responses to the second and third (booster) doses of coronavirus disease 2019 (COVID-19 ...
Risk factors for in-hospital mortality in cancer patients hospitalized for COVID-19. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text ...
Adults aged 50 years and older demonstrate strong, durable immune responses after receiving an additional dose of the recombinant zoster vaccine.
Antibody-mediated rejection (ABMR) remains the leading immunological cause of kidney allograft loss, yet its humoral origins are incompletely understood.